Researchers uncover molecular changes associated with treating lymphatic filariasis

September 26, 2019

The Global Program to Eliminate Lymphatic Filariasis delivers mass drug administration to 500 million people each year, and adverse events are common following treatment. Now, researchers have reported in PLOS Neglected Tropical Diseases that certain changes in gene expression are associated with these adverse events.

Lymphatic filariasis (LF) is a neglected tropical disease caused by the mosquito-borne parasites Wuchereria bancrofti, Brugia malayi, and B. timori. Mass drug administration (MDA) to prevent LF and reduce transmissions generally rely on annual treatment with combinations of two or three drugs. Although treatment is safe, transient mild to moderate systemic adverse events--such as joint pain, fever, rash, or cough-- are common in individuals with circulating microfilariae in the blood. Since these adverse events (AEs) are quite uncommon in uninfected individuals, they are believed to be triggered by host responses to dying filarial worms rather than the drugs themselves.

In the new work, Britt Andersen of Washington University School of Medicine, USA, and colleagues studied blood samples from 95 individuals being treated for LF. Nine of these participants experienced moderate AEs, 24 had mild AEs, and 62 had no AEs. Levels of filarial antigens and immune proteins, as well as DNA transcription signatures were studied.

The researchers found that levels of filarial antigens increased after treatment in individuals with AEs, and this suggests that AEs are triggered nu host responses to dying parasites. AEs were associated with elevations in serum levels of certain immune molecules called cytokines. Moreover, when the team compared patterns of gene expression in white blood cells between people with moderate AEs and those without AEs, they found 744 genes upregulated in people with AEs, including many genes involved in immune signaling.

"Improved understanding of the pathogenesis of adverse events may lead to improved management, increased MDA compliance, and accelerated LF elimination," the researchers say.
In your coverage please use this URL to provide access to the freely available paper:

Citation: Andersen BJ, Rosa BA, Kupritz J, Meite A, Serge T, et al. (2019) Systems analysis-based assessment of post-treatment adverse events in lymphatic filariasis. PLOS Neglected Tropical Diseases 13(9): e0007697.

Funding: This work was supported in part by grant GH5342 from the Bill and Melinda Gates Foundation and by a grant from the Foundation for Barnes-Jewish Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.


Related Lymphatic Filariasis Articles from Brightsurf:

New source of lymphatic system leak discovered in children with rare open heart surgery complication
Interventional radiologists with Nemours Children's Health System have identified a new source of abnormal lymphatic flow between the liver and the lungs that may be responsible for some cases of plastic bronchitis.

Researchers use precision medicine to reverse severe lymphatic disorder
Through genetic sequencing and targeted treatment, researchers from Children's Hospital of Philadelphia (CHOP) have resolved a severe lymphatic disorder in a young woman with kaposiform lymphangiomatosis (KLA), a complex and rare disorder that causes lymphatic vessels around the heart and lung to leak fluid, causing breathing difficulties, infections, and often death.

Acidic niche keeps lymphatic system in check during immune response
In a new article published in Nature Communications, Moffitt Cancer Center researchers describe a novel acidic niche within lymph nodes that plays an integral role in regulating T cell activation.

Biomedical scientists piece together how medication paralyzes parasitic worms
A new study upends the widely held belief that a medication used to treat lymphatic filariasis doesn't directly target the parasites that cause the disease.

Researchers identify 'hot spots' for developing lymphatic vessels
The development of the lymphatic vasculature is crucially dependent on one specific protein -- the growth factor VEGF-C.

Lymphatic vessels in mice and humans: Alike yet different
In an international collaboration, researchers from Uppsala University have mapped the lymph node lymphatic vessels in mice and humans down to the level of individual cells.

Study finds molecule in lymphatic system implicated in autoimmune diseases
A study by investigators at Hospital for Special Surgery (HSS) has discovered a molecule in the lymphatic system that has the potential to play a role in autoimmune disease.

Meningeal lymphatic network: A new avenue in the treatment of brain tumors
Glioblastomas are the most common type of brain tumor, and their prognosis is often highly unfavorable.

An international study discovers a new origin of lymphatic vessels in the heart
A study published today in Development Cell opens the way to future research into the mechanism of lymphatic vessel formation in this new niche and the functional diversity of cardiac lymphatics.

Lymphatic system found to play key role in hair regeneration
To grow new hair, stem cells throughout the skin must work in sync.

Read More: Lymphatic Filariasis News and Lymphatic Filariasis Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to